Skip to main content

Table 3 Health-related quality of life of patients on HAART vs. those awaiting HAART

From: Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study

  All respondents (N = 371) Receiving HAART (N = 268) Awaiting HAART (N = 103) P-value
EQ-5 Dimensions n (%) n (%) n (%)  
Mobility     
   No problems 291 (78) 218 (81) 73 (71) 0.026*
   Some problems 73 (20) 48 (18) 25 (24)  
   Severe problems 7 (2) 2 (1) 5 (5)  
Self care     
   No problems 337 (91) 252 (94) 85 (83) 0.001*
   Some problems 24 (6) 13 (5) 11 (11)  
   Severe problems 10 (3) 3 (1) 7 (7)  
Usual activities**     
   No problems 289 (78) 216 (81) 73 (71) 0.07*
   Some problems 61 (16) 42 (16) 19 (18)  
   Severe problems 20 (5) 9 (3) 11 (11)  
Pain/discomfort     
   None 207 (56) 162 (60) 45 (44) 0.022*
   Some 140 (38) 92 (34) 48 (47)  
   Severe 24 (6) 14 (5) 10 (10)  
Depression/anxiety     
   None 248 (67) 188 (70) 60 (58) 0.15*
   Some 94 (25) 61 (23) 33 (32)  
   Severe 29 (8) 19 (7) 10 (10)  
Index score     
Median (IQR) 0.85 (0.69–1) 0.87 (0.73–1) 0.80 (0.66–1) 0.004$
Mean (SD) 0.77 (0.33) 0.80 (0.29) 0.69 (0.40)  
VAS score     
Median (IQR) 65 (50–80) 70 (50–80) 60 (50–70) 0.04$
Mean (SD) 65 (20) 66 (20) 62 (23)  
  1. * Ordinal logistic regression adjusted for intraclinic clustering of outcomes
  2. ** Information missing for 1 respondent
  3. $ Wilcoxon rank sum test
  4. Percentages for some dimensions do not add up to 100% because of rounding errors